Chugai started phase III clinical trial of Actemra for COVID-19 pneumonia in Japan
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
Amneal Pharmaceuticals donated hydroxychloroquine sulfate to state of Texas
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
BioMotiv and Bristol-Myers Squibb announced the Launch of Anteros Pharmaceuticals
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
Alexion completed acquisition of Achillion for $930 million
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
Biotechnology | CDC | FDA | NIH | Non-Profit Research | Pharmaceutical | Vaccine
CDC published updated ACIP recommendations for use of PCV13 and PPSV23 pneumococcal vaccines for adults age 65 and older
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
Purdue Pharma announced Chapter 11 bankruptcy and preliminary agreement to settle opioid litigation
On Sept. 15, 2019, Purdue Pharma filed for Chapter 11 bankruptcy and announced that it had reached an…
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics
CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
Chembio Diagnostics and Takeda Pharmaceutical announced collaboration to develop point-of-care diagnostic test
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
AstraZeneca closed Boulder-based LakeCentre and Longmont facilities
On Jan. 9, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers. AstraZeneca…
Takeda Pharmaceutical acquired Shire
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
Agriculture | Biotechnology | Life Science History | Medical Device | Nanotechnology | Non-Profit Research | Pharmaceutical | Therapeutics | Veterinary
Arizona Life Science Genealogy Published
On Aug. 9, 2018, Arizona Life Science Genealogy was published illustrating life science companies and non-profit research organization…
Teva Pharmaceuticals announced North America headquarters moved to New Jersey
On Jul. 6, 2018, Teva Pharmaceuticals announced it would move its U.S. headquarters to Parsippany-Troy Hills, New Jersey…
Agriculture | Biotechnology | Diagnostics | Disease | Life Science History | Medical Device | Oncology | Pharmaceutical | Veterinary
Texas Life Science Genealogy, 2018
Texas Life Science Genealogy illustrates life science companies and non-profit research organization in the State of Texas by…
Sanofi acquired Bioverativ for $11.6 billion
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
PNNL and OHSU created joint research co-laboratory to advance precision medicine
On Feb. 14, 2018, Pacific Northwest National Laboratory, (PNNL) and Oregon Health & Science University OHSU announced the…
Biotechnology | CDC | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
Celgene acquired Juno Therapeutics for $9 billion
On Jan. 22, 2018, Celgene and Juno Therapeutics announced the signing of a merger agreement in which Celgene…
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
Emory University’s Center for Selective C-H Functionalization was awarded a $20 million grant by the NSF to advance organic synthesis
On Oct. 2, 2017, Emory University’s Center for Selective C-H Functionalization (CCHF) was awarded a $20 million grant…
NIH expanded license agreement with Medigen Vaccines Biologics for Dengue vaccine from 17 to 26 countries
On Sept. 18, 2017, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
Achieve Life Sciences announced merger with OncoGenex Pharmaceuticals
On Aug. 1, 2017, Achieve Life Sciences announced it had merged with OncoGenex and was renamed Achieve Life…